Holen Sie sich die Stockscreener-App
4.88
5.06%
-0.26
Finanzdaten der Advanced Biomed Inc-Aktie (ADVB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
31.06%
0.5198
|
0.3966 | 0.5239 | 1.2125 | 0.7627 |
| Depreciation and Amortization |
172.54%
0.00933
|
-0.0129 | 0.048 | 0.0644 | 0.0781 |
| Nonoperating Income/Loss |
99.58%
0.0309
|
7.3988 | 0.137 | 0.5109 | -0.6211 |
| Income/Loss From Continuing Operations Before Tax |
106.98%
-0.4889
|
7.0022 | -0.3869 | -0.7016 | -1.3839 |
| Income/Loss From Continuing Operations After Tax |
106.98%
-0.4889
|
7.0022 | -0.3869 | - | -1.3839 |
| Income/Loss From Discontinued Operations, Net Of Tax |
100.00%
-
|
-0.1443 | -0.1282 | - | - |
| Net Income/Loss |
107.13%
-0.4889
|
6.8579 | -0.3869 | -0.7016 | -1.3839 |
| Basic Average Shares |
94.06%
1.2849
|
21.64 | 21.64 | - | 20.48 |
| Diluted Average Shares |
94.06%
1.2849
|
21.64 | 21.64 | - | 20.48 |
| Basic Earnings Per Share |
222.58%
-0.38
|
0.31 | -0.02 | - | -0.07 |
| Diluted Earnings Per Share |
222.58%
-0.38
|
0.31 | -0.02 | - | -0.07 |
6.81%
4.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):